Margherita Morpurgo

About Margherita Morpurgo

Margherita Morpurgo, With an exceptional h-index of 25 and a recent h-index of 12 (since 2020), a distinguished researcher at Università degli Studi di Padova, specializes in the field of drug delivery, In vitro diagnostics technologies, surface biofunctionalization.

His recent articles reflect a diverse array of research interests and contributions to the field:

Efficient SARS-CoV-2 infection antagonization by rhACE2 ectodomain multimerized onto the Avidin-Nucleic-Acid-NanoASsembly

RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia

From pharmaceutical technique toparhaceutical technology in 50 yers at the University of Padua

10th International Granulation Workshop

Development of a Nanoparticle-Based Approach for the Blood–Brain Barrier Passage in a Murine Model of Amyotrophic Lateral Sclerosis

Semisolid wet Sol–Gel Silica/Hydroxypropyl methyl cellulose formulation for slow release of Serpin B3 promotes wound healing in vivo

Angiotensin II promotes SARS-CoV-2 Infection via upregulation of ACE2 in human bronchial cells

The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence

Margherita Morpurgo Information

University

Position

Assistant Professor Pharmaceutical and Pharmacologialc Sciences Italy

Citations(all)

2555

Citations(since 2020)

556

Cited By

2193

hIndex(all)

25

hIndex(since 2020)

12

i10Index(all)

43

i10Index(since 2020)

18

Email

University Profile Page

Google Scholar

Margherita Morpurgo Skills & Research Interests

drug delivery

In vitro diagnostics technologies

surface biofunctionalization

Top articles of Margherita Morpurgo

Efficient SARS-CoV-2 infection antagonization by rhACE2 ectodomain multimerized onto the Avidin-Nucleic-Acid-NanoASsembly

Biomaterials

2023/12/1

RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia

Journal of Clinical Medicine

2023/10/19

From pharmaceutical technique toparhaceutical technology in 50 yers at the University of Padua

2023

10th International Granulation Workshop

2023

Margherita Morpurgo
Margherita Morpurgo

H-Index: 14

Development of a Nanoparticle-Based Approach for the Blood–Brain Barrier Passage in a Murine Model of Amyotrophic Lateral Sclerosis

Cells

2022/12/10

Margherita Morpurgo
Margherita Morpurgo

H-Index: 14

Semisolid wet Sol–Gel Silica/Hydroxypropyl methyl cellulose formulation for slow release of Serpin B3 promotes wound healing in vivo

Pharmaceutics

2022/9/14

Angiotensin II promotes SARS-CoV-2 Infection via upregulation of ACE2 in human bronchial cells

International Journal of Molecular Sciences

2022/5/4

The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence

Nanomedicine: Nanotechnology, Biology and Medicine

2022/2/1

Nanoassembled complexes of nucleic acids, avidin and biotinylated compounds for use as drug carriers

2021/3/9

Estabilidad de matrices de SiO2 sintetizadas por el método Sol-Gel

Revista de Ciencias Farmaceúticas y Biomedicina

2020/12/23

Margherita Morpurgo
Margherita Morpurgo

H-Index: 14

UTILIZZO DEI SISTEMI PER CHIRURGIA AD ALTA ENERGIA PER EMOSTASI E SINTESI VASALE (A RADIOFREQUENZA/ULTRASUONI) RISPETTO ALL’ELETTROCHIRURGIA CONVENZIONALE NELL’EMORROIDECTOMIA

2020

Margherita Morpurgo
Margherita Morpurgo

H-Index: 14

See List of Professors in Margherita Morpurgo University(Università degli Studi di Padova)